Uncertainty related to sales volumes and margins for 2024 remains. Our EBITDA changes are mainly related to production problems in Martinez and in Singapore.
But the company should overcome ramp-up problems and we believe Q2 could be a catalyst in terms of SAF sales and margins.
We reiterate our Buy recommendation and DCF-based target price of EUR 49.